{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:59:24Z","timestamp":1789639164822,"version":"4.0.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073204"],"award-info":[{"award-number":["82073204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202040157"],"award-info":[{"award-number":["202040157"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biocel.2023.106389","type":"journal-article","created":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T09:50:26Z","timestamp":1676195426000},"page":"106389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["E2F1-mediated ectopic expression of PP1A promotes breast cancer progression via activation of YAP1"],"prefix":"10.1016","volume":"157","author":[{"given":"Xiaochong","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amik","family":"Munankarmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2418-3617","authenticated-orcid":false,"given":"Lin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2023.106389_bib1","doi-asserted-by":"crossref","first-page":"8184","DOI":"10.1074\/jbc.RA118.006920","article-title":"Dephosphorylation of the transcriptional cofactor NACA by the PP1A phosphatase enhances cJUN transcriptional activity and osteoblast differentiation","volume":"294","author":"Addison","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biocel.2023.106389_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.annonc.2020.11.011","article-title":"Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1","volume":"32","author":"Andr\u00e9","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biocel.2023.106389_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab1113","article-title":"JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles","volume":"50","author":"Castro-Mondragon","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biocel.2023.106389_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41467-017-02272-y","article-title":"Deregulated PP1\u03b1 phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biocel.2023.106389_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2023.106389_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41419-021-04105-9","article-title":"MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor","volume":"12","author":"Deng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biocel.2023.106389_bib7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","article-title":"Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine","volume":"19","author":"Dey","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biocel.2023.106389_bib8","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1158\/0008-5472.CAN-20-1031","article-title":"ERINA is an estrogen-responsive LncRNA that drives breast cancer through the E2F1\/RB1 pathway","volume":"80","author":"Fang","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.biocel.2023.106389_bib9","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal"},{"key":"10.1016\/j.biocel.2023.106389_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108703","article-title":"PPP1CA\/YAP\/GS\/Gln\/mTORC1 pathway activates retinal M\u00fcller cells during diabetic retinopathy","volume":"210","author":"Guo","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biocel.2023.106389_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa942","article-title":"Ensembl 2021","volume":"49","author":"Howe","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biocel.2023.106389_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.stem.2017.03.023","article-title":"An FAK-YAP-mTOR signaling axis regulates stem cell-based tissue renewal in mice","volume":"21","author":"Hu","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biocel.2023.106389_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13046-020-01561-7","article-title":"Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer","volume":"39","author":"Hua","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biocel.2023.106389_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1470-2045(19)30164-0","article-title":"Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Jiang","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biocel.2023.106389_bib15","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biocel.2023.106389_bib16","article-title":"The Smad4-MYO18A-PP1A complex regulates \u03b2-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma","author":"Liu","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biocel.2023.106389_bib17","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biocel.2023.106389_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","article-title":"The Hippo pathway: biology and pathophysiology","volume":"88","author":"Ma","year":"2019","journal-title":"Annu Rev. Biochem"},{"key":"10.1016\/j.biocel.2023.106389_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2021.02.022","article-title":"LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction","volume":"506","author":"Ma","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biocel.2023.106389_bib20","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.cmet.2021.11.011","article-title":"NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis","volume":"33","author":"Park","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.biocel.2023.106389_bib21","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1038\/ncomms11479","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biocel.2023.106389_bib22","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1158\/0008-5472.CAN-20-2801","article-title":"YAP and \u03b2-catenin cooperate to drive oncogenesis in basal breast cancer","volume":"81","author":"Quinn","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.biocel.2023.106389_bib23","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1016\/j.cell.2021.10.014","article-title":"RNA promotes the formation of spatial compartments in the nucleus","volume":"184","author":"Quinodoz","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2023.106389_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-019-1007-8","article-title":"Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups","volume":"567","author":"Rueda","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2023.106389_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12253-015-9928-5","article-title":"Nuclear protein phosphatase 1 \u03b1 (PP1A) expression is associated with poor prognosis in p53 expressing glioblastomas","volume":"22","author":"Shastry","year":"2016","journal-title":"Pathol. Oncol. Res"},{"key":"10.1016\/j.biocel.2023.106389_bib26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(20)30165-3","article-title":"Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future","volume":"395","author":"Spring","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biocel.2023.106389_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ebiom.2019.08.061","article-title":"USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK\/MAPK signaling pathway","volume":"48","author":"Sun","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biocel.2023.106389_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab835","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biocel.2023.106389_bib29","doi-asserted-by":"crossref","first-page":"x3","DOI":"10.1093\/annonc\/mdz281","article-title":"Overview of the relevance of PI3K pathway in HR-positive breast cancer","volume":"30","author":"Vasan","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biocel.2023.106389_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"Jama"},{"key":"10.1016\/j.biocel.2023.106389_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/21655979.2021.2012316","article-title":"Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer","volume":"13","author":"Xie","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.biocel.2023.106389_bib32","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/s41591-021-01562-9","article-title":"Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial","volume":"27","author":"Xu","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.biocel.2023.106389_bib33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41568-019-0168-y","article-title":"YAP and TAZ: a signalling hub of the tumour microenvironment","volume":"19","author":"Zanconato","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biocel.2023.106389_bib34","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1038\/s41467-019-12543-5","article-title":"Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272523000286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272523000286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:42:49Z","timestamp":1778600569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272523000286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":34,"alternative-id":["S1357272523000286"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2023.106389","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E2F1-mediated ectopic expression of PP1A promotes breast cancer progression via activation of YAP1","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2023.106389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106389"}}